The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Richard Ronald since 2015.
This trader's CIK number is 1380177.
At the time of last reporting, Richard Ronald was the Director of Emergent Biosolutions Inc.. (stock ticker symbol EBS).
Also see all insider trading activities at Emergent Biosolutions Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | EBS | 0 | $0 | 21,984 | $263,917 | 25,748 | $129,254 |
| 2022 | EBS | 0 | $0 | 1,912 | $22,829 | 0 | $0 |
| 2020 | EBS | 0 | $0 | 34,289 | $3,022,216 | 13,045 | $254,524 |
| 2019 | EBS | 0 | $0 | 5,153 | $309,180 | 5,153 | $96,051 |
| 2018 | EBS | 0 | $0 | 31,021 | $1,849,463 | 23,679 | $324,244 |
| 2017 | EBS | 0 | $0 | 47,362 | $2,013,477 | 47,362 | $441,175 |
| 2016 | EBS | 0 | $0 | 27,500 | $1,065,030 | 21,600 | $182,088 |
| 2015 | EBS | 0 | $0 | 14,767 | $505,817 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-12-05 | EBS | Option Ex | 25,748 | 5.02 | 129,254 |
| 2025-12-05 | EBS | Sale | 21,984 | 12.01 | 263,917 |
| 2022-11-25 | EBS | Sale | 1,912 | 11.94 | 22,829 |
| 2020-08-07 | EBS | Sale | 6,297 | 131.00 | 824,907 |
| 2020-06-03 | EBS | Sale | 6,572 | 87.51 | 575,142 |
| 2020-05-05 | EBS | Sale | 8,375 | 80.19 | 671,633 |
| 2020-04-27 | EBS | Option Ex | 7,893 | 20.08 | 158,491 |
| 2020-04-27 | EBS | Sale | 7,893 | 78.00 | 615,654 |
| 2020-02-21 | EBS | Sale | 5,152 | 65.00 | 334,880 |
| 2020-02-21 | EBS | Option Ex | 5,152 | 18.64 | 96,033 |
| 2019-11-07 | EBS | Option Ex | 5,153 | 18.64 | 96,051 |
| 2019-11-07 | EBS | Sale | 5,153 | 60.00 | 309,180 |
| 2018-11-07 | EBS | Option Ex | 7,893 | 13.00 | 102,609 |
| 2018-11-07 | EBS | Sale | 7,893 | 70.00 | 552,510 |
| 2018-08-21 | EBS | Option Ex | 7,793 | 14.71 | 114,635 |
| 2018-08-21 | EBS | Sale | 7,793 | 60.02 | 467,712 |
| 2018-08-03 | EBS | Option Ex | 100 | 14.71 | 1,471 |
| 2018-08-03 | EBS | Sale | 100 | 60.00 | 6,000 |
| 2018-06-06 | EBS | Sale | 7,342 | 53.00 | 389,126 |
| 2018-04-17 | EBS | Option Ex | 7,893 | 13.37 | 105,529 |
| 2018-04-17 | EBS | Sale | 7,893 | 55.00 | 434,115 |
| 2017-12-12 | EBS | Option Ex | 23,681 | 10.64 | 251,965 |
| 2017-12-12 | EBS | Sale | 23,681 | 45.02 | 1,066,237 |
| 2017-09-28 | EBS | Sale | 22,415 | 40.00 | 896,600 |
| 2017-09-27 | EBS | Sale | 1,266 | 40.00 | 50,640 |
| 2017-09-28 | EBS | Option Ex | 22,415 | 7.99 | 179,095 |
| 2017-09-27 | EBS | Option Ex | 1,266 | 7.99 | 10,115 |
| 2016-12-13 | EBS | Sale | 5,900 | 34.07 | 201,030 |
| 2015-12-30 | EBS | Option Ex | 21,600 | 8.43 | 182,088 |
| 2015-12-30 | EBS | Sale | 21,600 | 40.00 | 864,000 |
| 2015-08-13 | EBS | Sale | 4,922 | 36.00 | 177,192 |
| 2015-07-13 | EBS | Sale | 4,922 | 34.00 | 167,348 |
| 2015-06-29 | EBS | Sale | 4,923 | 32.76 | 161,277 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Richard Ronald (Director of Emergent Biosolutions Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.